drugset / Trial / NCT03294330
SPY-X: A Study to Assess the Feasibility of Using SPY Alone for Sentinel Node Localization for Melanoma or Breast Cancer
Phase 3
Completed
35 enrolled
Milton S. Hershey Medical Center
Emory University · collabVassar Brothers Medical Center · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The objective of this study is to determine if fluorescence lymphangiography can be used alone to localize sentinel nodes in patients with melanoma or breast cancer. The hypothesis is that sentinel nodes can be identified using only indocyanine green (ICG) and fluorescence lymphangiography, without the need for technetium99 and a gamma probe.
Timeline
- Start
- 2017-10-11
- Primary completion
- 2021-09-17
- Completion
- 2021-11-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.3 ml | Other |
| Subject | Indocyanine Green | Diagnostic / imaging agent | 1 ml | Other |